No photo of Yazen Alnouti

View Scopus Profile

Yazen Alnouti, PhD

  • 2417 Citations
  • 28 h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yazen Alnouti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence

Fox, H. S., Fletcher, C. V., Boska, M. D., Gendelman, H. E., Kabanov, A., Alnouti, Y. & Bronich, T. K.

National Institutes of Health

12/1/09 → 6/30/20

Project: Research project

    • Research Output

    • 2417 Citations
    • 28 h-Index
    • 73 Article
    • 4 Review article
    • 1 Paper

    A year-long extended release nanoformulated cabotegravir prodrug

    Kulkarni, T. A., Bade, A. N., Sillman, B., Shetty, B. L. D., Wojtkiewicz, M. S., Gautam, N., Hilaire, J. R., Sravanam, S., Szlachetka, A., Lamberty, B. G., Morsey, B. M., Fox, H. S., Alnouti, Y., McMillan, J. E. M., Mosley, R. L., Meza, J., Domanico, P. L., Yue, T. Y., Moore, G., Edagwa, B. J. & 1 others, Gendelman, H. E., Aug 1 2020, In : Nature Materials. 19, 8, p. 910-920 11 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples

    Gautam, N., Alamoudi, J. A., Kumar, S. & Alnouti, Y., Jan 30 2020, In : Journal of Pharmaceutical and Biomedical Analysis. 178, 112902.

    Research output: Contribution to journal › Review article

    • Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice

    Wei, X., Zhao, G., Wang, X., Gautam, N., Jia, Z., Zhao, Z., Kong, D., Zhang, F., Kumar, S., Sun, Y., Chen, N., Wang, X., Yang, L., Ren, R., Thiele, G. M., Bronich, T. K., O'Dell, J. R., Alnouti, Y. & Wang, D., Oct 2020, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 29, 102266.

    Research output: Contribution to journal › Article

    • KVA-D-88, a Novel Preferable Phosphodiesterase 4B Inhibitor, Decreases Cocaine-Mediated Reward Properties in Vivo

    Burkovetskaya, M. E., Liu, Q., Vadukoot, A. K., Gautam, N., Alnouti, Y., Kumar, S., Miczek, K., Buch, S., Hopkins, C. R. & Guo, M., Aug 5 2020, In : ACS Chemical Neuroscience. 11, 15, p. 2231-2242 12 p.

    Research output: Contribution to journal › Article

    • Synthesis and Characterization of Long-Acting Darunavir Prodrugs

    Banoub, M. G., Bade, A. N., Lin, Z., Cobb, D., Gautam, N., Dyavar Shetty, B. L., Wojtkiewicz, M., Alnouti, Y., McMillan, J., Gendelman, H. E. & Edagwa, B., Jan 6 2020, In : Molecular Pharmaceutics. 17, 1, p. 155-166 12 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations